Costs Retaxed Against State After Judgment For Novo Nordisk In FCA Drug Dispute
TACOMA, Wash. — After a jury found in favor of Novo Nordisk Inc. (NNI) in a qui tam suit accusing it of violating the federal False Claims Act (FCA) and similar...To view the full article, register now.
Already a subscriber? Click here to view full article